Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
BIOMARKER:
HRAS G13R
i
Other names:
HRAS, HRAS1, Harvey rat sarcoma viral oncogene homolog
Associations
(10)
Heatmap
News
Twitter
Trials
C3 | Sensitive
D | Sensitive
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Chemokine
Serine-Threonine Kinase Inhibitors
Tyrosine Kinase Inhibitors
Threonine-Tyrosine Kinase Inhibitors
Kinase Inhibitors
Cancel
Urothelial Cancer
Squamous Cell Carcinoma of Head and Neck
Thyroid Gland Carcinoma
Thyroid Gland Anaplastic Carcinoma
Solid Tumor
tipifarnib
C3
HRAS G13R
|
Urothelial Cancer
|
tipifarnib
D
HRAS G13R
|
Squamous Cell Carcinoma of Head and Neck
|
tipifarnib
FRAX597
D
HRAS G13R
|
Thyroid Gland Carcinoma
|
FRAX597
trametinib + dasatinib
D
HRAS G13R
|
Thyroid Gland Carcinoma
|
trametinib + dasatinib
trametinib
D
HRAS G13R
|
Thyroid Gland Carcinoma
|
trametinib
D
HRAS G13R
|
Solid Tumor
|
trametinib
dasatinib + SCH772984
D
HRAS G13R
|
Thyroid Gland Carcinoma
|
dasatinib + SCH772984
dasatinib + selumetinib
D
HRAS G13R
|
Thyroid Gland Carcinoma
|
dasatinib + selumetinib
selumetinib
D
HRAS G13R
|
Thyroid Gland Carcinoma
|
selumetinib
CI-1040
D
HRAS G13R
|
Thyroid Gland Anaplastic Carcinoma
|
CI-1040
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
